Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback